Recurrent Glioblastoma: Where we stand

Sanjoy Roy; Debarshi Lahiri; Tapas Maji; Jaydip Biswas

doi:10.4103/2278-330X.175953

This article has been cited by
1	Ovatodiolide Inhibits the Oncogenicity and Cancer Stem Cell-like Phenotype of Glioblastoma Cells, as well as Potentiate the Anticancer Effect of Temozolomide
	Yu-kai Su,Oluwaseun Adebayo Bamodu,Yew-Min Tzeng,Michael Hsiao,Chi-Tai Yeh,Chien-Min Lin
	Phytomedicine. 2019; : 152840
	[Pubmed] \| [DOI]

2	A COMPARISON BETWEEN X-RAY AND CARBON ION IRRADIATION IN HUMAN NEURAL STEM CELLS
	J Morini,G Babini,S Barbieri,G Baiocco,M Ciocca,G B Ivaldi,M Liotta,S Molinelli,P Tabarelli de Fatis,A Ottolenghi
	Radiation Protection Dosimetry. 2018;
	[Pubmed] \| [DOI]

3	Spontaneous Glioblastoma Spheroid Infiltration of Early-Stage Cerebral Organoids Models Brain Tumor Invasion
	Bárbara da Silva,Ryan K. Mathew,Euan S. Polson,Jennifer Williams,Heiko Wurdak
	SLAS DISCOVERY: Advancing Life Sciences R&D. 2018; 23(8): 862
	[Pubmed] \| [DOI]

4	*Towards an advanced cell-based in vitro* glioma model system**
	Valeriia Mikhailova,Valeriia Gulaia,Vladlena Tiasto,Stanislav Rybtsov,Margarita Yatsunskaya,Alexander Kagansky
	AIMS Genetics. 2018; 5(2): 91
	[Pubmed] \| [DOI]

5	Identifying glioblastoma margins using dual-targeted organic nanoparticles for efficient in vivo fluorescence image-guided photothermal therapy
	Xiaolei Cai,Aishwarya Bandla,Chan Kim Chuan,Gayathiri Magarajah,Lun-De Liao,Daniel Boon Loong Teh,Brian K. Kennedy,Nitish V. Thakor,Bin Liu
	Materials Horizons. 2018;
	[Pubmed] \| [DOI]

6	Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma
	Bryan G. Harder,Mylan R. Blomquist,Junwen Wang,Anthony J. Kim,Graeme F. Woodworth,Jeffrey A. Winkles,Joseph C. Loftus,Nhan L. Tran
	Frontiers in Oncology. 2018; 8
	[Pubmed] \| [DOI]

7	Radiation-Induced Alterations in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications
	Kshama Gupta,Terry C. Burns
	Frontiers in Oncology. 2018; 8
	[Pubmed] \| [DOI]

8	Approved Treatments for Patients with Recurrent High-grade Gliomas
	Caroline Kane Laub,Jennifer Stefanik,Lisa Doherty
	Seminars in Oncology Nursing. 2018;
	[Pubmed] \| [DOI]

9	Folate receptor-targeted novel boron compound for boron neutron capture therapy on F98 glioma-bearing rats
	Takuya Kanemitsu,Shinji Kawabata,Masao Fukumura,Gen Futamura,Ryo Hiramatsu,Naosuke Nonoguchi,Fumiko Nakagawa,Takushi Takata,Hiroki Tanaka,Minoru Suzuki,Shin-Ichiro Masunaga,Koji Ono,Shin-Ichi Miyatake,Hiroyuki Nakamura,Toshihiko Kuroiwa
	Radiation and Environmental Biophysics. 2018;
	[Pubmed] \| [DOI]

10	Localized targeted antiangiogenic drug delivery for glioblastoma
	Gregory D. Arnone,Abhiraj D. Bhimani,Tania Aguilar,Ankit I. Mehta
	Journal of Neuro-Oncology. 2018;
	[Pubmed] \| [DOI]

11	Bright Future for Novel Viral Glioblastoma Multiforme Therapy
	David McCarthy,Dallas Sheinberg,Ricardo J. Komotar,Robert M. Starke
	World Neurosurgery. 2018;
	[Pubmed] \| [DOI]

12	Molecular biology as a tool for the treatment of cancer
	Carla de Castro Sant’ Anna,Alberto Gomes Ferreira Junior,Paulo Soares,Fabricio Tuji,Eric Paschoal,Luiz Cláudio Chaves,Rommel Rodriguez Burbano
	Clinical and Experimental Medicine. 2018;
	[Pubmed] \| [DOI]

13	Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection
	C. Bastiancich,J. Bianco,K. Vanvarenberg,B. Ucakar,N. Joudiou,B. Gallez,G. Bastiat,F. Lagarce,V. Préat,F. Danhier
	Journal of Controlled Release. 2017;
	[Pubmed] \| [DOI]

14	Validation of an established prognostic score after re-irradiation of recurrent glioma
	Kerstin A. Kessel,Josefine Hesse,Christoph Straube,Claus Zimmer,Friederike Schmidt-Graf,Jürgen Schlegel,Bernhard Meyer,Stephanie E. Combs
	Acta Oncologica. 2017; : 1
	[Pubmed] \| [DOI]

15	Advances in Brain Tumor Surgery for Glioblastoma in Adults
	Montserrat Lara-Velazquez,Rawan Al-Kharboosh,Stephanie Jeanneret,Carla Vazquez-Ramos,Deependra Mahato,Daryoush Tavanaiepour,Gazanfar Rahmathulla,Alfredo Quinones-Hinojosa
	Brain Sciences. 2017; 7(12): 166
	[Pubmed] \| [DOI]

16	Randomized Trial for Short-Term Radiation Therapy With Temozolomide in Elderly Patients With Glioblastoma
	David J. McCarthy,Ricardo J. Komotar,Robert M. Starke,E. Sander Connolly
	Neurosurgery. 2017; 81(3): N21
	[Pubmed] \| [DOI]

17	Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line
	Benxu Cheng,Liza Doreen Morales,Yonghong Zhang,Shizue Mito,Andrew Tsin,Salvatore V Pizzo
	PLOS ONE. 2017; 12(9): e0184324
	[Pubmed] \| [DOI]

18	Identification of Driver Genes and Key Pathways of Glioblastoma Shows JNJ-7706621 as a Novel Antiglioblastoma Drug
	Sheng Zhong,Bo Wu,Xuechao Dong,Yujuan Han,Shanshan Jiang,Ying Zhang,Yang Bai,Sean X. Luo,Yong Chen,Huimao Zhang,Gang Zhao
	World Neurosurgery. 2017;
	[Pubmed] \| [DOI]

19	Recurrent glioblastoma: a single-institution experience with reirradiation and temozolomide
	Tejinder Kataria,Deepak Gupta,Ratika Gupta,Shikha Goyal,Shyam Singh Bisht,Trinanjan Basu,Ashu Abhishek,Kushal Narang,Susovan Banerjee
	Journal of Radiation Oncology. 2017;
	[Pubmed] \| [DOI]

20	A highly potent CDK4/6 inhibitor was rationally designed to overcome blood brain barrier in gliobastoma therapy
	Lei Yin,Heng Li,Wenjian Liu,Zhenglin Yao,Zhenzhen Cheng,Huabei Zhang,Hui Zou
	European Journal of Medicinal Chemistry. 2017;
	[Pubmed] \| [DOI]

21	Harnessing nanomedicine for therapeutic intervention in glioblastoma
	Anna Gutkin,Zvi R. Cohen,Dan Peer
	Expert Opinion on Drug Delivery. 2016; : 1
	[Pubmed] \| [DOI]